Results 101 to 110 of about 14,546 (260)
Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure
ABSTRACT Background and Aims The impact of portal hypertension (PH) during acute‐on‐chronic liver failure (ACLF) remains unclear. This study investigated the link between underlying PH severity, systemic inflammation (SI), and the course of ACLF. Methods Consecutive patients with ACLF (n = 192) who met the EASL‐CLIF criteria were retrospectively ...
Vlad Taru+11 more
wiley +1 more source
A case of fatal cutaneous caput medusae hemorrhage
Key Clinical Message Alcoholic liver cirrhosis leads to portal venous hypertension, which can result in a caput medusae formation. Life‐threatening hemorrhage from a ruptured caput medusae vein is a rare complication.
Nikolaos Melas+2 more
doaj +1 more source
The Role of TIPS in Patients with Refractory Ascites and Portal Vein Thrombosis
Nowadays the contraindication for transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal vein thrombosis (PVT) had been modify. The experience and technology have reduce the complications for this procedure.
Paulina Chinchilla-López+4 more
doaj +1 more source
Peristomal variceal hemorrhage at the ileal conduit site due to extrahepatic portosystemic shunt
Peristomal variceal bleeding is a rare but known complication with portal hypertension. In patients with recurrent peristomal hemorrhage, atypical varices should be considered, and liver cirrhosis should be excluded even with normal liver function tests.
Smitha Narayana Gowda+2 more
doaj +1 more source
Background Ultrasound (US) surveillance for transjugular intrahepatic portosystemic shunt (TIPS) dysfunction has yet to be standardized, as clear-cut criteria have not been conventionally defined.
Rareș Crăciun+8 more
doaj +1 more source
Transjugular intrahepatic portosystemic shunt: Where are we?
The purpose of this study was to evaluate the technical/hemodynamic success, complications, and biochemical/ hematologic consequences of transjugular intrahepatic portosystemic shunt (TIPS) created with 10-mm bare stents in our patients.Data of 27 cirrhotic patients (18 men and 9 women; mean age, 39.7±18.7 years) with a median MELD score 14 (range 7-31)
Serkan Ocal+6 more
openaire +3 more sources
Pathophysiological and clinical approach to cirrhotic cardiomyopathy. [PDF]
Hyperdynamic circulation, systolic and diastolic left ventricular dysfunction and certain electrophysiological abnormalities have been associated with cirrhosis and known for a long time.
Czifra, Árpád+5 more
core
BACKGROUND & AIMS: Manganese (Mn) deposition could be responsible for the T(1)-weighted magnetic resonance signal hyperintensities observed in cirrhotic patients.
Butterworth, Roger+8 more
core +1 more source
We report successful management of transjugular intrahepatic portosystemic shunt stent infection (endotipsitis) following direct intrahepatic portocaval shunt for chronic Budd–Chiari syndrome. PETCT confirmed FDG-avid vegetation/thrombus within the stent
Nischal G. Kundaragi+3 more
doaj +1 more source
Transcaval Transjugular Intrahepatic Portosystemic Shunt: Preliminary Clinical Results [PDF]
Objective To determine the feasibility of transcaval transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with unusual anatomy between the hepatic veins and portal bifurcation, and inaccessible or inadequate hepatic veins.
Blum+25 more
core +2 more sources